Ami Organics Limited - Asset Resilience Ratio
Ami Organics Limited (AMIORG) has an Asset Resilience Ratio of 4.11% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Ami Organics Limited balance sheet liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2014–2025)
This chart shows how Ami Organics Limited's Asset Resilience Ratio has changed over time. See Ami Organics Limited (AMIORG) shareholders funds for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Ami Organics Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Ami Organics Limited (AMIORG) market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 0% |
| Short-term Investments | Rs637.04 Million | 4.11% |
| Total Liquid Assets | Rs637.04 Million | 4.11% |
Asset Resilience Insights
- Limited Liquidity: Ami Organics Limited maintains only 4.11% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Ami Organics Limited Industry Peers by Asset Resilience Ratio
Compare Ami Organics Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Air Products and Chemicals Inc
NYSE:APD |
Specialty Chemicals | 2.49% |
|
AKZO NOBEL SPONS.ADRS 1/3
F:AKUP |
Specialty Chemicals | 2.16% |
|
Kingfa Sci&Tech Co Ltd
SHG:600143 |
Specialty Chemicals | 0.02% |
|
Zhongfu Shenying Carbon Fiber Co. Ltd. A
SHG:688295 |
Specialty Chemicals | 2.48% |
|
Arkema SA
PA:AKE |
Specialty Chemicals | 13.81% |
|
Baoding Lucky Innovative Materials Co Ltd
SHE:300446 |
Specialty Chemicals | 0.23% |
|
Yibin Tianyuan Group Co Ltd
SHE:002386 |
Specialty Chemicals | 0.00% |
|
Longkou Union Chemical Co. Ltd. A
SHE:301209 |
Specialty Chemicals | 21.72% |
Annual Asset Resilience Ratio for Ami Organics Limited (2014–2025)
The table below shows the annual Asset Resilience Ratio data for Ami Organics Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-03-31 | 4.11% | Rs637.04 Million ≈ $6.89 Million |
Rs15.49 Billion ≈ $167.55 Million |
+1.96pp |
| 2024-03-31 | 2.15% | Rs236.07 Million ≈ $2.55 Million |
Rs10.96 Billion ≈ $118.52 Million |
-1.51pp |
| 2023-03-31 | 3.67% | Rs281.38 Million ≈ $3.04 Million |
Rs7.67 Billion ≈ $82.94 Million |
-4.11pp |
| 2022-03-31 | 7.78% | Rs512.50 Million ≈ $5.54 Million |
Rs6.59 Billion ≈ $71.26 Million |
+7.70pp |
| 2021-03-31 | 0.08% | Rs3.20 Million ≈ $34.60K |
Rs4.13 Billion ≈ $44.69 Million |
-1.40pp |
| 2020-03-31 | 1.48% | Rs34.32 Million ≈ $371.16K |
Rs2.32 Billion ≈ $25.08 Million |
+1.20pp |
| 2019-03-31 | 0.28% | Rs5.91 Million ≈ $63.91K |
Rs2.13 Billion ≈ $23.05 Million |
+0.13pp |
| 2018-03-31 | 0.15% | Rs2.31 Million ≈ $24.98K |
Rs1.56 Billion ≈ $16.82 Million |
-0.24pp |
| 2017-03-31 | 0.39% | Rs4.22 Million ≈ $45.64K |
Rs1.09 Billion ≈ $11.80 Million |
+0.19pp |
| 2016-03-31 | 0.20% | Rs1.86 Million ≈ $20.12K |
Rs923.89 Million ≈ $9.99 Million |
-0.14pp |
| 2015-03-31 | 0.34% | Rs2.02 Million ≈ $21.85K |
Rs592.05 Million ≈ $6.40 Million |
-0.03pp |
| 2014-03-31 | 0.37% | Rs1.43 Million ≈ $15.46K |
Rs387.10 Million ≈ $4.19 Million |
-- |
About Ami Organics Limited
Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson's, antidepressant, and anticoagulant applications, as wel… Read more